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RESEARCH QUESTION
1 Which tracers have been used in (pre)clinical (animal) studies to investigate the 
use of optical-guided surgery in mucosal head and neck squamous cell carcinomas 
(HNSCC)?
2 Which tracers have had positive/negative results and should (not) be utilized in 
further research?
RESULTS
A total of 53 studies analyzed macroscopic fluorescent probes for the detection of HNSCC.
 ‒ 49 preclinical trials
 ‒ 4 clinical trials using anti-EGFR antibodies 
METHODS
Databases used: Medline, Web of Science & Embase 
Included: 
 ‒ Molecular specific probes for macroscopic identification
 ‒ Mucosal squamous cell cancers of the head and neck in 
 ‒ Animal models or clinical trials
CONCLUSION
The current review collects all (pre-)clinical manuscripts discussing the use of 
fluorescence-labelled antigen guided surgery patients or animal models with 
squamous cell carcinomas of the head and neck. The epidermal growth factor receptor 
is the most analyzed antigen in preclinical studies, and is the only antigen that made it 
to clinical trials at the time of writing. There are however multiple different antigens 
described on HNSCC with equivalent preclinical results. Future research should further 
focus on improving the antigen sensitivity and specificity by comparing the multiple 
antigens in different cell types. 
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Because of its important role in oncological curation, surgical oncology has radically advanced over the last decades with new techniques and technological improvements resulting 
in better outcome and survival in cancer patients. However, one prominent risk factor remains the complete removal of the solid tumor with acceptable margins. In head and neck 
cancer, when tumor cells remain present in the patient postoperatively, a significantly lower chance of curation is described and these patients are hence referred for further adjuvant 
therapies. This has led to the recent development of intra-operative optical guidance to visualize the tumor margins by use of fluorescence. The field of optical guided surgery has 
evolved tremendously over the last couple of years, resulting in an explosion of different tracers. This sudden growth of optical guided surgery has led to an unclear overview of 
the tracers used in the field. The current systematic review aimed at systematically collecting all different molecular specific probes studied in animal models and clinical trials for 
their application in the optical visualization of head and neck squamous cell cancer specifically. 
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MOLECULAR-SPECIFIC OPTICAL GUIDED SURGERY IN HEAD AND NECK SQUAMOUS 
CELL CANCER, A SYSTEMATIC REVIEW OF ANIMAL MODELS AND CLINICAL TRIALS. 
